Clinical Trial Update: miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial [Phase 1]

View source ↗

Summary

Phase 1 trial of miroliverELAP for acute liver failure has been completed. The document provides an update on the trial status by Miromatrix Medical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis
• Drug-induced Liver Injury
• Liver Failure
• On Chronic Liver Failure

Drugs mentioned

• miroliverELAP

Snippet

Sponsor: Miromatrix Medical Inc. | Conditions: Acute Liver Failure, Acute Liver Injury, Drug Induced | Phase 1 | Status: COMPLETED